Company news
Sareum Holdings Plc (LSE:SAR) news
Sareum Holdings Plc news releases on 6ix. Latest, Nov 23, 2023: Drawdown of Equity Prepayment Facility
Press releases — page 2
Drawdown of Equity Prepayment Facility
November 23, 2023
Initiation of food effects study for SDC-1801
November 9, 2023
Director Dealings
November 8, 2023
Sareum enhances SDC-1801 patent protection
November 3, 2023
Exercise of Share Options and Director Dealings
November 2, 2023
Final Results for the Year Ended 30 June 2023
October 9, 2023
Director's Dealing
September 6, 2023
Director Dealing
September 5, 2023
Dosing of first subjects in MAD Phase 1a trial
September 4, 2023
Update on financial and operational progress
August 16, 2023
Equity Prepayment Facility of up to £5 million
August 3, 2023
Sareum Announces Two New Granted Patents
June 26, 2023
Dosing commences in Phase 1a trial of SDC-801
June 6, 2023
Phase 1a clinical trial for SDC-1801
May 18, 2023
Approval to initiate Phase 1 clinical trial
May 5, 2023
Half-Year Report
March 22, 2023
Update on SDC-1801
March 15, 2023
Notice of Half-Year Results
March 15, 2023
Director/PDMR Shareholding
December 29, 2022
Sareum : AGM Statement
December 16, 2022
Sareum notes publication of SRA737 clinical data
November 21, 2022
Second Price Monitoring Extn
November 9, 2022
Price Monitoring Extension
November 9, 2022
Update on SDC-1801 CTA Application
November 8, 2022
Final Results for the Year Ended 30 June 2022
October 24, 2022
Sareum : Update on SAR737
October 12, 2022
Sareum notes FDA approval of first TYK2 Inhibitor
September 12, 2022
CTA application to MHRA and Corporate Update
July 28, 2022
Sareum notes GSK's completed acquisition of Sierra
July 4, 2022
Sareum to Present at BioTrinity 2022 Conference
April 26, 2022
Sareum notes acquisition of Sierra Oncology by GSK
April 13, 2022
European Patent Granted for Sareum's SDC-1802
April 11, 2022
SDC-1801: Preclinical Toxicology Report Received
March 16, 2022
Results of EGM
February 28, 2022
Half-year Report
February 21, 2022
Publication of Circular; Notice of General Meeting
February 4, 2022
Correction - Issue of Warrants
January 28, 2022
Issue of Warrants
January 28, 2022
Sareum to Participate in Edison Open House Event
January 25, 2022
Subscription to raise £1.63m to progress SDC-1801
December 17, 2021
Result of AGM
December 16, 2021
Intention to grant notice - EU patent for SDC-1802
December 15, 2021
AGM Update
December 7, 2021
Notice of AGM
November 19, 2021
Sareum: Final Results for Year Ended 30 June 2021
October 25, 2021
Correction - Notice of Results
October 21, 2021
US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor
October 7, 2021
Reference to SRA737 Timeline at Cantor Conference
September 29, 2021
Trading Statement
August 19, 2021
Subscription to raise £1,000,000
August 9, 2021